Emcure Pharmaceuticals IPO subscription

Emcure Pharmaceuticals IPO: 10 key risks investors should consider before subscribing to the 1,952-crore issue

2024-07-03 23:45:03 Emcure Pharmaceuticals IPO sails through first day of bidding smoothly led by non institutional and retail investors. The…

3 months ago